GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

by

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the journal eClinicalMedicine finds that first-generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss.

Leave A Comment

Your email address will not be published. Required fields are marked *